Tricuspid Valve Reconstruction Using the Right Atrial Appendage
Trial Snapshot
- Phase
- Not Applicable
- Status
- Enrolling By Invitation
- Sponsor
- Zagazig University
- Enrollment
- 30
- Locations
- 3
- Primary Endpoint
- Mortality
Study Overview
Brief Summary
we use part of the cardiac chambre for replacement of destroyed valve on right side of the heart
Detailed Description
Tricuspid Valve Reconstruction Using the Right Atrial Appendage by harvesting appropriate size then reconstruction as bileaflet valve after reinforcement of the annulus by pericardial band then the neovalve fixed to papillary muscles of the right ventricle by artificial chorda anchored by teflon pledgets
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •all patient need tricuspid valve replacement
Exclusion Criteria
- •patient refusal
Arms & Interventions
right atrial appendage
right atrial appendage used for tricuspid valve reconstruction
Intervention: Tricuspid Valve Reconstruction (Procedure)
tissue valve
tissue valve used for tricuspid valve replacement
Intervention: tricuspid valve replacement (Procedure)
Outcomes
Primary Outcomes
Mortality
Time Frame: 30 day post operative
perioperative and short-term mortality, with no major procedure-related surgical complication
Morbidity
Time Frame: 30 day post operative
measuring pressure gradient
Time Frame: 6 months postoperative
Follow-up echocardiography by measuring pressure gradient across the neo valve
Thromboembolic Risk checklist
Time Frame: 6 months postoperative
Secondary Outcomes
No secondary outcomes reported
Investigators
Amr Elsayed Tawfek Ibrahim
assistant prof
Zagazig University